Atovaquone

Discontinued Product

Atovaquone (Cat. No. 6358) has been withdrawn from sale for commercial reasons.
Cat.No. 6358 - Atovaquone | C22H19ClO3 | CAS No. 95233-18-4
Description: Inhibits complex III of mitochondrial electron transport chain in parasites
Chemical Name: 2-[trans-4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione
Purity: ≥98% (HPLC)
Datasheet
Citations
Reviews

Biological Activity for Atovaquone

Broad spectrum antiparasitic and antipneumocystic compound. Inhibits bc1 complex (complex III) of mitochondrial electron transport chain (EC50 = 0.26 μM), causing cell death in Plasmodium yoelii infected erythrocytes. Also inhibits DHODH. Also exhibits anti-MERS-CoV activity in Vero cells in vitro (IC50 = 0.72 μM).

Technical Data for Atovaquone

M. Wt 366.84
Formula C22H19ClO3
Storage Store at -20°C
Purity ≥98% (HPLC)
CAS Number 95233-18-4
PubChem ID 74989
InChI Key BSJMWHQBCZFXBR-UHFFFAOYSA-N
Smiles O=C1C(O)=C([C@H]2CC[C@H](C3=CC=C(Cl)C=C3)CC2)C(C4=CC=CC=C41)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

References for Atovaquone

References are publications that support the biological activity of the product.

Hughes et al (1990) Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis. Antimicrob.Agents Chemother. 34 225 PMID: 2327770

Srivastava et al (1997) Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite. J.Biol.Chem. 272 3961 PMID: 9020100

Ko et al (2020) Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19. BioRxiv - Paper not yet peer reviewed

View Related Products by Product Action

View all Oxidative Phosphorylation Inhibitors

Keywords: Atovaquone, Atovaquone supplier, atovaquone, antimalarial, antiparasitic, mitochondria, respiration, inhibitors, inhibits, DHODH, dihydroorotate, dehydrogenase, COVID-19, SARS-CoV-2, severe, acute, respiratory, syndrome, MERS, Oxidative, Phosphorylation, Dihyroorotate, Dehydrogenase, Antimalarials, Coronavirus, 6358, Tocris Bioscience

Citations for Atovaquone

Citations are publications that use Tocris products.

Currently there are no citations for Atovaquone.

Reviews for Atovaquone

There are currently no reviews for this product. Be the first to review Atovaquone and earn rewards!

Have you used Atovaquone?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review